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Terfizia claveryi was examined for in vitro antibacterial activity using the disc diffusion, well diffusion 
method, minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). T. 
claveryi exhibited excellent antibacterial activity against all clinical isolates of corneal ulcer tested, 
especially against Pseudomonas aeruginosa which showed the maximum antibacterial activity with 
mean zone of inhibition 20.33 mm at concentration of 100 mg/ml. The MIC for Staphylococcus aureus 
ranged from 0.040-1.250 mg/ml and MBC for Escherichia coli was 75 μl/ml. In the present study, the MIC 
value of the active aqueous extract were lower than the MBC values suggesting that, T. claveryi 
aqueous extracts were bacteriostatic at lower concentration but bactericidal at higher concentration. 
Also, the bacterial zone of inhibition increased with the increasing concentration of T. claveryi aqueous 
extract. To the best of our knowledge, this is the first report for the novel antibacterial activity of T. 
claveryi aqueous extract. This active compound may be used as alternative therapeutic drug for the 
control of corneal infections. However, further research is needed to examine its in vivo mechanism of 
action, toxicity, and therapeutic effect. 
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 century antibiotic resistance of clinical bacterial 
isolates are increasing drastically, the search for new and 
safe anti-bacterial compounds are important and natural  
medicinal products seems to be a logical and effective 
source for seeking new antimicrobial agents.  In Saudi 
Arabi, the traditional medicinal practices have been 
known since ancient time for their unique properties and 
obvious therapeutic potential in treating a variety of 
diseases (Al-Bukhari and Al-Bukhari, 1996).  
Terfizia claveryi, as brown desert truffles, are 
considered to be one of the oldest food stuffs known for 
their nutritional value especially when compared with 
meat and fish (Abu-Rabia, 1983). Truffle aqueous extract 
is used as a folk medicine in Gulf countries (Iraq, Saudi 
Arabia and Eastern Jordan) to treat eye infections 
(Bokhairy and Parvez, 1993).  T. claveryi ascocarps 
contain 16% protein, 28% total carbohydrates, 4% total 
crude fiber, 2% total crude fat and rich in mineral as well 
as carbohydrate contents, with nine saturated and four 
unsaturated fatty acids and 29 amino acids, unique 
flavor, nutritional value and medicinal properties for a 
variety of ailments (Al-Delaimy, 1977). It is also used as a 
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nourishing and invigorating preparation for convalescents 
in Mediterranean countries (Janakat et al., 2004). 
Corneal infection is one of the most common ocular 
diseases in both humans and animals and can lead to 
blindness (Olivier, 2003; Jatoi et al., 2002). There are 
various pathogenic organisms, like Staphylococcus 
aureus, Pseudomonas aeruginosa, Streptococcus spp. 
and Staphylococcus epidermis, reported to cause corneal 
infection (Wahl et al., 1991; Dart, 1988; Charteris et al., 
1994; Leeming, 1999).
 
Many antibacterial preparations 
are used to treat eye infections such as, chloramphenicol, 
fluoroquinolone, neomycin and aminoglycosides (Goldstein 
et al., 1999).  However, the increasing resistance of many 
bacteria and the side effects to the currently used 
antibiotics are documented (Lancaster and Swart, 1998; 
Ostier, 1993; Vaughan and Asbury, 1980; Skies et al., 
2007).  The medicinally important T. claveryi fruit was 
selected in this study to investigate whether having 




MATERIALS AND METHODS 
 
Collection of Terfizia claveryi 
 
“Kamma” the local name of T. claveryi, brown desert truffles was 
purchased in April-2012 from the local market in Riyadh, Kingdom 
of Saudi Arabia. The desert truffle fruit material identification was 
confirmed by Department of food and Agriculture, Qassim 
University, Kingdom of Saudi Arabia. 
 
 
Preparation of crude extract of T. claveryi 
 
The collected T. claveryi fruits were cleaned and cut into small 
pieces and dried under shade at room temperature. The dried 
material was ground to fine powder using a mechanical blender and 
passed through 24 mesh sieve. T. claveryi powder (100 g) was 
extracted with 50 mM sodium phosphate buffer (pH 7.0) at 37°C. 
The extract was filtered through cheese cloth to remove the major 
debris and the filtrate was centrifuged at 10,000 rpm for 15 min at 
4°C. The supernatant was considered as crude aqueous extract of 
T. claveryi and stored at 4°C for experimental use. 
 
 




Microbial cultures of eight different strains of both Gram positive 
and Gram negative bacteria were used for the determination of 
antibacterial activity. Gram-positive (S. aureus, S. epidermidis, 
Staphylococcus faecalis) and Gram-negative (Escherichia coli, P. 
aeruginosa, Pseudomonas vulgaris, Klebsiella pneumonia), clinical 
bacterial isolates were used. All the bacterial strains were sub-
cultured at 37°C on Mueller-Hinton agar (Oxoid, Hampshire, UK) 
slants every 15 days and stored at 4°C. The bacterial isolates were 
obtained during parallel studies from clinical cases that suffered 
corneal infections and subjected to several hospitals at Qasssim 
region during 2012. Sampling, culturing, isolation and identification 
were done in the Department medical laboratory at College of 
Applied Medical Sciences, Qassim University using the standard 
Microbiology techniques (Collee et al., 1996). 




Antibiotic susceptibility testing 
 
The microorganisms were tested for their sensitivity against the 
antibiotics including: Ciprofloxacin (5 μg), tetracycline (30 μg), 
gentamycin (10 μg), tobramycin (10 μg), erythromycin (15 μg), 
moxifloxacin (5 μg), cefoxitin (30 μg), oxacillin (1 μg), clotrimazole 
(10 μg). The susceptibilities of the isolated pathogens were 
determined by the modified Kirby-Bauer disc diffusion method with 
Muller Hinton agar plates (Bauer et al., 1996). All the media used in 




Agar well diffusion method 
 
Antibacterial activity of T. claveryi was determined by agar well 
diffusion method (Bauer et al., 1996). One hundred microliter (100 
μl) of standardized inoculum (0.5 Mac-Farland) of each test 
bacterium were inoculated on molten Mueller-Hinton agar, 
homogenized and poured into sterile plates. Standard cork borer of 
various diameter (6, 16 and 20 mm) were used to make uniform 
wells into which different amounts of aqueous extract of T. claveryi 
(100, 300 and 500 μl) were added. Standard antibiotic ciprofloxacin 
was used as positive control and 50 mM sodium phosphate buffer 
alone was used as negative control. The plates were then 
incubated at 37 ± 1°C for 24 h. The experiments were carried out in 




Determination of minimum inhibitory concentrations (MIC) 
 
The MIC of T. claveryi was determined by macro dilution method 
(Weckesser et al., 2007).
 
 Several dilutions of Terfizia aqueous 
extracts ranges (0.040-1.250 mg/ml) and standard antibiotic ranges 
(0.024-0.240 mg/ml) were prepared from stock solutions by serial 
dilution technique. Each sample dilution were mixed properly with 
20 ml of sterile molten Muller Hinton agar and poured into 90 mm 
plates and allowed to cool under laminar air flow before streaking 
with 10 μl of 0.5 McFarland standards. The lowest concentration 
which did not show any macroscopic growth of tested 
microorganism was identified as the MIC. 
 
 
Determination of minimal bactericidal concentration (MBC) 
 
The MBC of the T. claveryi extracts were determined by a macro 
broth dilution method (Perez et al., 1990). Each set contains 8 
tubes as follows: Positive control, negative control, positive control 
with 50 mM potassium phosphate buffer pH 7 where 50, 75, 100, 
125, 150, 175 and 200 μl of T. claveryi aqueous extract were added 
for each bacterial species. 7 tubes out of eight were inoculated with 
10 μl of single bacterial species. The plates were then incubated at 
37°C overnight and the lowest dilution that yielded complete 
inhibition of bacterial growth was taken as the MBC. Each of the 
extract was tested in triplicate and the average values were 





These parameters were tested in triplicates. The values were 
expressed as mean ± standard deviation (SD), mean value ± 
standard error of the mean (SEM) of growth inhibition zones 
diameters obtained with aqueous extract which amount was 
sufficient to perform repetitions. Statistical differences between the 
two variants of diffusion method were detected by analysis of 
variance (ANOVA) followed by Duncan test, the statistical analysis 
was performed using SPSS statistical software. 




Table 1. Mean zone of inhibition (mm) of T. claveryi aqueous extracts against bacterial isolates in comparison 
with standard antibiotic. 
 
Bacterial isolate 
Mean zone of inhibition (mm) (mean ± SD) 
T. claveryi (100 mg/ml) Standard antibiotic (ciprofloxacin 5 mg/disc) 
Staphylococcus aureus 19.00± 1.00 27.33±0.57 
Staphylococcus epidermidis 18.00± 1.00 29.00±0.57 
Streptococcus faecalis 17.00± 1.00 28.66± 1.52 
Escherichia coli 15.33± 0.57 30.33± 1.52 
Pseudomonas aeruginosa 20.33± 1.00. 26.00± 1.52 
Proteus vulgaris 15.33± 0.57 27.66± 0.57 






Mean zone of inhibition 
 
In the present study, all the tested bacteria were sensitive 
to T. claveryi aqueous extract. Among the Gram positive 
and Gram negative; S. aureus, P. aeruginosa exhibited 
highest rate of sensitivity to T. claveryi aqueous extract. 
This study also reveals that the P. aeruginosa was 
highest susceptible bacteria with 20.33 mm zone of 
inhibition followed by S. aureus (19.00 mm), S. 
epidermidis (18.00 mm), S. faecalis (17.00 mm), E. coli 
(15.33 mm), P. vulgaris (15.33 mm) and K. pneumonia 
(14.66 mm) at the test concentration of 100 mg/ml, which 
was comparable to standard antibiotic ciprofloxacin 5 
mg/disc (Table 1). 
 
 
Minimum inhibitory concentration (MIC) and 
minimum bactericidal concentration (MBC) 
 
Our results exhibited the broad spectra of antibacterial 
activity of T. claveryi aqueous extract (Figure 1). The MIC 
and MBC of T. claveryi aqueous extract against clinical 
isolates has been listed in (Tables 2 and 3). The MIC 
ranged between 0.40 to 1.25 mg/ml and the MIC of 
ciprofloxacin ranged between 0.024 to 0.240 mg/ml. 
Among the Gram positive bacteria strain, S. aureus iso-
lates were found to be more sensitive than Gram nega-
tive K. pneumonia strains. T. claveryi extracts exhibited 
the greatest antibacterial activities as determined by the 
MBC. The MBC ranged between 75 to 120 µl/ml.  
The lowest MBC value was observed towards S. 
aureus (75 μl/ml) and K. pneumonia (85 μl/ml). The 
inhibition of tested bacteria was increased by the 
increase in the amount of the T. claveryi aqueous extract 
(Table 4 and Figure 2).  
In all clinical bacterial isolates, antibiotic susceptibility 
to eight antibiotics was accessed by Kirby-Bauer disc 
diffusion method (Table 5). All bacterial isolates were 
sensitive to ciprofloxacin while S.  aureus and S. faecalis 
were resistant to erythromycin.   
DISCUSSION 
 
Saudi Arabia has old history in the use of diverse herbal 
medicines for traditional healing. Literature overview 
shows that, the most common species of the genus 
Terfizia especially Terfizia claveryi are round, tan to 
brown like small sandy potatoes, have unique flavor, 
nutritional value and medicinal properties. It is used for 
treatment of variety of ailments like eye infections, open 
cuts, stomach ailment among others (Goldstein et al., 
1999; Lancaster and Swart, 1998). In Gulf countries, 
Truffle is used in the form of flour or juice for curing 
various infections in folk medicine. 
Numerous studies have been reported in the past, 
focusing on antimicrobial activity of aqueous extract of 
Asparagus racemosus1, Asphodelust enuifolius, Balanites 
aegyptiaca, Eclipta alba, Pedalium murex, 
Ricinuscommunis, Trigonellafoenumgraecum, 
TrianthemadecandraL, Argemone mexicana, 
Tinosporacordifolia and Cassia fistula  against various 
bacteria and fungi by using well diffusion and disc 
diffusion methods (Satavat and Gupta, 1987; Kaul 
(1997); Valsaraj et al., 1997; Khafagy and Ishrak, 1999; 
Mandal et al., 2000; Geethalakshmi et al., 2010; Rahman 
et al., 2011;  Upadhyay et al., 2011). The antimicrobial 
analysis using the agar well diffusion method and MIC 
value had been used by many researchers (Arora and 
Kaur, 2007; Gurudeeban et al., 2010; Pavithra et al., 
2010). However, since no studies have been reported on 
the antimicrobial activity of T. claveryi extracts against 
bacterial isolates causing corneal ulcer, we made this 
attempt.
 
Several herbal medicines like Pothomorphe umbellate 
extract and Chinese herbal medicine (emodin) have been 
reported to play an important role in the therapeutic 
activities of corneal ulcerative problems (Barros et al., 
2007; Kitano et al., 2007). The effects of S. jalambrensis 
preparation on ocular inflammation have been explored 
by in vivo topical administration. The scientific research 
on the antimicrobial potency of many of the plants and 
herbs used for medicinal purposes in Saudi Arabia is 
lacking.  










Table 2. Minimum inhibitory concentrations (MICs) of T. claveryi aqueous extract 
against bacterial isolates in comparison with standard antibiotic. 
 
Bacterial isolate 
MIC value (mg/ml) 
T. claveryi Standard antibiotic (ciprofloxacin) 
Staphylococcus aureus 0.40 0.024 
Staphylococcus epidermidis 0.40 0.024 
Streptococcus  faecalis 0.75 0.120 
Escherichia coli 0.60 0.195 
Pseudomonas aeruginosa 0.55 0.240 
Proteus vulgaris 1.20 0.124 
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Fig. 1  Efficiency  of Terfizia claveryi aqueous extract against different 
bacteria compared with standard antibiotic (Ciprofloxacin) 
B. Escherichia coli C. Klebsiella pnemoniae 











Table 3. Minimum Bactericidal concentrations (MBC) of T. claveryia aqueous extract 
against bacterial isolates in comparison with standard antibiotic. 
 
Bacterial isolate 
MBC value (μl/ml) 
T. claveryi Standard antibiotic (ciprofloxacin) 
Staphylococcus aureus 75 0.024 
Staphylococcus epidermidis 75 0.024 
Streptococcus  faecalis 90 0.120 
Escherichia coli 95 0.195 
Pseudomonas aeruginosa 100 0.240 
Proteus vulgaris 120 0.124 








T. claveryi aqueous extract 
100 μl 300 μl 500 μl 
Well (6 mm) Well (16 mm) Well (20 mm) 
Staphylococcus aureus 19 34 41 
Staphylococcus epidermidis 20 33 40 
Streptococcus faecalis 17 27 32 
Escherichia coli 18 28 33 
Pseudomonas aeruginosa 16 26 30 
Klebsiella pneumonia 16 26 30 






Figure 2. Effect of Terfizia claveryi aqueous extract against tested bacteria isolates. 















Table 5. Antibiotic susceptibility pattern of Gram positive and Gram negative bacteria. 
 
Test organism CIP CN TE TOB E MXF FOX OX 
Staphylococcus aureus S S S S R S R R 
Staphylococcus epidermidis S S S S S S S S 
Streptococcus faecalis S R R S R S R ND 
Escherichia coli S S S S S S S ND 
Pseudomonas aeruginosa S S R S S S R ND 
Klebsiella pneumonia S S S S S S S ND 
Proteus mirabilis S R R S R S S ND 
 
ND, Not determined; R, resistance; S, sensitive; CIP, ciprofloxacin; CN, cefoxitin; TE, 




So, the present investigation evaluates the in-vitro antimi-
crobial activity of crude extracts of T. claveryi against the 
clinical bacterial isolates causing corneal ulcer.  In the 
present study, we found that, T. claveryi extracts showed 
good antibacterial activity against most of the clinical 
bacterial isolates from the corneal ulcer cases (Table 1 
and Figure 1).  
The results of the current study clearly demonstrate 
that, aqueous extracts of T. claveryi could inhibit the 
growth of several bacterial pathogens causing cornea 
ulcer. However, the effectiveness varied against the dif-
ferent tested bacterial isolates. We determined the po-
tential antibacterial activity of T. claveryi aqueous extract 
against seven clinical bacterial isolates causing corneal 
ulcer. The zone of inhibition for the T. claveryi extracts 
obtained by disc diffusion were equal or larger than those 
of the eight antibiotics commonly used to treat corneal 
ulcer infections (Table. 5). 
In the present study, the MIC value of the active 
aqueous extract were lower than the MBC values 
suggesting that, the T. claveryi aqueous extracts were 
bacteriostatic at lower concentration but bactericidal at 
higher concentration (Tables 2 and 3).  The mean zone of 
inhibition as shown in (Table 4 and Figure 2) was 
increased by the increase in the amount of the T. claveryi 
aqueous extract (Maji et al., 2010). The current results 
highlights, the fact that T. claveryi aqueous extracts 
exhibited antimicrobial activity against Gram positive and 
Gram negative bacteria isolated from corneal ulcer. Con-
sidering that these T. claveryi are edible and are tradi-
tionally used for treatment of a number of ailments, their 
anti-bacterial activity is quite significant and could present 





To the best of our knowledge, this is the first report for 
the novel anti-bacterial activity of T. claveryi aqueous 
extract against bacterial isolates causing corneal ulcer. 
This active compound may be used as an alternative 
therapeutic drug for the control of corneal infections. 
Further  research   is   needed   to   examine   its    in-vivo  
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